Daiwa Securities Group Inc. Seres Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$5.09 - $9.05 $951 - $1,692	187 Added 59.55%	501 $3,000
Q3 2021 Nov 05, 2021	BUY	$5.46 - $22.6 $775 - $3,209	142 Added 82.56%	314 $2,000
Q4 2020 Feb 04, 2021	SELL	$23.25 - $37.73 $6,347 - $10,300	-273 Reduced 61.35%	172 $4,000
Q3 2019 Nov 04, 2019	BUY	$2.29 - $4.16 $506 - $919	221 Added 98.66%	445 $2,000
Q1 2018 May 02, 2018	BUY	$7.34 - $11.16 $1,644 - $2,499	224 New	224 $2,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.